PRESENTATION

Q3 2023 — Earnings presentation

Q3 2023PDF · 22 pages1.6 MB
2023 Third Quarter Earnings
(unaudited)
Mike Roman
Chairman of the Board and
Chief Executive Officer
Monish Patolawala
President and Chief
Financial Officer
Bruce Jermeland
Senior Vice President,
Investor Relations

-- 1 of 22 --

2
2023 Q3 Earnings | October 24, 2023. All rights reserved.
This presentation contains forward-looking information about 3M’s financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements
by the use of words such as “plan,” “expect,” “aim,” “believe,” “project,” “target,” “anticipate,” “intend,” “estimate,” “will,” “should,” “could,” “would,” “forecast” and other words and terms of similar
meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the
following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company’s control, including inflation,
recession, military conflicts, natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to unexpected events such as the public
health crises associated with the coronavirus (COVID-19) global pandemic; (3) foreign currency exchange rates and fluctuations in those rates; (4) risks related to certain fluorochemicals, including
liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company’s plans to exit PFAS
manufacturing and discontinue use of PFAS across its product portfolio; (5) risks related to the proposed class-action settlement (“PWS Settlement”) to resolve claims by public water systems in the
United States regarding PFAS, including whether court approval of the PWS Settlement will be obtained, whether the number of plaintiffs that opt out of the PWS Settlement will exceed current
expectations or will exceed the level that would permit 3M to terminate the PWS Settlement (and whether 3M will elect to terminate the PWS Settlement if this occurs), whether the PWS Settlement is
appealed, the timing and amount of payments made under the PWS Settlement, and the impact of the PWS Settlement on other PFAS-related matters; (6) legal proceedings, including significant
developments that could occur in the legal and regulatory proceedings described in the Company’s Annual Report on Form 10-K for the year ended Dec. 31, 2022 and any subsequent quarterly reports on
Form 10-Q (the “Reports”); (7) competitive conditions and customer preferences; (8) the timing and market acceptance of new product and service offerings; (9) the availability and cost of purchased
components, compounds, raw materials and energy due to shortages, increased demand and wages, supply chain interruptions, or natural or other disasters; (10) unanticipated problems or delays with the
phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company’s information technology infrastructure; (11) the impact of
acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (12) operational execution, including the extent
to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (13) financial market risks that may affect the
Company’s funding obligations under defined benefit pension and postretirement plans; (14) the Company’s credit ratings and its cost of capital; (15) tax-related external conditions, including changes in
tax rates, laws or regulations; (16) matters relating to the proposed spin-off of the Company’s Health Care business; and (17) matters relating to Combat Arms Earplugs (“CAE”), including those relating to
the voluntary chapter 11 proceedings of the Company’s subsidiary Aearo Technologies and certain of its affiliates (“Aearo Entities”), as well as those related to the August 2023 settlement that is intended
to resolve, to the fullest extent possible, all litigation and alleged claims involving the CAE sold or manufactured by the Aearo Entities and/or 3M (“CAE Settlement”), including, but not limited to, whether
the anticipated participation by plaintiffs in the CAE Settlement will be achieved, whether the number of plaintiffs that participate in the CAE Settlement will meet current expectations or will fall below
the level that would permit 3M to terminate the CAE Settlement (and whether 3M will elect to terminate the CAE Settlement if this occurs), whether there will be a significant number of future claims by
plaintiffs that decline to participate in the CAE Settlement, whether the CAE Settlement is appealed or challenged, whether the requirements applicable to the issuance of the equity securities that are
contemplated to be part of the CAE Settlement will be met, the filing of additional, or the outcome of any other pending or future, litigation relating to the products that are the subject of the CAE
Settlement, or changes in related laws or regulations. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports
under “Cautionary Note Concerning Factors That May Affect Future Results” and “Risk Factors” in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). The
Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.
Note on non-GAAP financial measures
This presentation refers to certain non-GAAP financial measures. Refer to 3M’s October 24, 2023, press release for descriptions of non-GAAP financial measures such as adjusted net sales (and
adjusted sales change); adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted net cash provided by (used in) operating activities; adjusted free
cash flow; adjusted free cash flow conversion; net debt; adjusted EBITDA (and adjusted EBITDA margin); and various measures that adjust for the impacts of special items. These non-GAAP measures
are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found
in that press release.
Forward-looking statements

-- 2 of 22 --

3
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Our priorities: Spinning off
Health Care
Reducing risk and
uncertainty
Driving performance
throughout 3M
1 2 3

-- 3 of 22 --

4
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Reducing risk
and uncertainty
• Announced settlement agreement intended to
resolve all Combat Arms Earplugs claims
• Court granted preliminary PFAS settlement
agreement approval
Spinning off
Health Care
• Progressing toward 1H 2024 completion
• Building strong leadership team and Board
Advancing our priorities in Q3:
Driving performance
throughout 3M
• Strong operational execution delivered 160 bps of YoY
adjusted operating income margin expansion; sequential
improvement across all business groups
• Progressing with restructuring to streamline the organization
by reducing structural cost, and optimizing commercial
models to be closer to customers
• Advancing supply chain performance to improve service,
drive productivity and yield, expand gross margins, and
increase cash conversion
• Positioning 3M for future growth, including investments in
automotive electrification, climate technology, and industrial
automation
1 2
3

-- 4 of 22 --

5
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Q3 2023 performance
Increasing full-year adjusted earnings to $8.95 to $9.15
and adjusted free cash flow conversion to 100% to 110%
Building momentum through operational execution
Adj. organic growth of -3.1%
Includes ~(1.7) ppt headwind from
disposable respirator decline and 2022
exit of Russia
• End-market trends largely in-
line with expectations
– Softness in electronics,
consumer retail, and China
– Disposable respirator decline
in-line with expectations
– Strength in automotive OEM
• Adjusted op. income margin
up 160 bps YoY, including 80
bps of restructuring & related
charges
• Adjusted op. income margin
up 390 bps sequentially
• All business groups delivered
significant sequential margin
improvement
• Adjusted free cash flow
conversion of 130%
• Relentless focus on working
capital management
• Continuing to invest in
growth, productivity, and
sustainability
• Adjusted EPS up 3% YoY
• Strong operational execution
• Ongoing proactive spending
discipline
• Includes $0.10 per share
restructuring & related
charges (prior guidance
midpoint of $0.22)
Adjusted Sales of $8B
vs. $7.9 to $8B guidance
Adjusted Op. Income
Margin of 23.2%
Adjusted EPS of $2.68
vs. $2.25 to $2.40 guidance
Adjusted Free Cash
Flow of $1.9B

-- 5 of 22 --

6
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Q3 2023 operating margin and EPS
Adjusted
operating
margin
Adjusted
earnings
per share Commentary
Q3 2022 21.6% $2.60
Total organic growth/
productivity/other +2.6% +$0.22
Disposable respirator/Russia Exit -0.4% -$0.09 • Decline in COVID-related disposable respirator demand and 2022 exit of operations in Russia
Remaining organic growth/
productivity/other +3.0% +$0.31
• Benefits from productivity actions, restructuring, strong spending discipline, and selling price
• Partially offset by lower sales volumes (particularly electronics, consumer retail, and China) and
investments in growth, productivity, and sustainability
Restructuring & related charges -0.8% -$0.10 • Q3 2023 pre-tax charge of $68M
Raw material -0.3% -$0.03 • Carryover impact of raw material, logistics, and energy cost inflation
FX 0.0% +$0.01 • U.S. dollar strength
Acquisition/Divestiture* +0.1% $0.00 • Food Safety divestiture; Aearo Technologies reconsolidation
Other expense/income NA -$0.02 • Primarily non-op pension
Adjusted tax rate** NA -$0.07 • Q3 2023 adjusted tax rate of 18.1% versus 15.9% in Q3 2022
Shares outstanding NA +$0.07 • Average diluted shares down 2.6% YoY
Q3 2023 23.2% $2.68
* Includes lost income from divested businesses and remaining stranded costs (net of transition arrangement income).
** The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above.

-- 6 of 22 --

7
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Adjusted free cash flow
$1.9B
Adjusted free cash flow
conversion
130%
Cash returned to
shareholders
$0.8B
Adjusted free cash flow • Q3: $1.9B, up 39% YoY
• YTD: $4.3B, up 37% YoY
Adjusted free cash flow
conversion
• Q3: 130%, up 360 bps YoY
• Q3 YoY increase driven by strong inventory management
• YTD: 115%, up 430 bps YoY
Adjusted capital
expenditures
• Q3: $367M, down 6% YoY
• YTD: $1.1B, up 2% YoY
Net debt • Q3: $10.8B, down 11% YoY
Capital returned to
shareholders • Q3: dividends $0.8B
• YTD: dividends $2.5B
Q3 2023 cash flow and balance sheet

-- 7 of 22 --

2023 Q3 Earnings | October 24, 2023. All rights reserved.
Business Group performance
Safety &
Industrial
Transportation &
Electronics Health Care Consumer

-- 8 of 22 --

9
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Q3 2023 commentary
• Organic growth performance:
– Low-double digit decline in closure and masking; high-single digit declines
in industrial adhesives and tapes and personal safety; mid-single digit
decline in abrasives; low-single digit declines in electrical markets and
automotive aftermarket
– High-single digit increase in roofing granules
– Disposable respirator/Russia YoY headwind of ~$130M, or -58%
organically; reduced segment organic growth by 4.3 ppts
• Industrial end-market demand mixed; distributors right-sizing inventory levels
• Adjusted operating margin up 250 bps YoY; up 350 bps sequentially
– YoY increase driven by:
▪ Benefits from productivity actions, restructuring, strong spending
discipline, and price
▪ Partially offset by lower sales volume and higher restructuring costs
Organic growth
-5.8%
Includes ~(4.3) ppt headwind from disposable
respirator decline and 2022 exit of Russia
Adjusted operating margin
25.7%
Safety & Industrial

-- 9 of 22 --

10
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Q3 2023 commentary
• Adjusted organic growth performance
– Low-double digit increase in automotive and aerospace; low-single digit
increase in advanced materials
– Mid-single digit decline in electronics, commercial solutions, and
transportation safety
• Consumer electronics end-markets stabilizing; closely watching seasonal
demand trends
• Adjusted operating margin up 460 bps YoY; up 650 bps sequentially
– YoY increase driven by:
▪ Benefits from productivity actions, restructuring, strong spending
discipline, and price
▪ Partially offset by lower sales volume and higher restructuring costs
Adjusted organic growth
-1.8%
Adjusted operating margin
26.3%
Transportation & Electronics

-- 10 of 22 --

11
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Q3 2023 commentary
• Organic growth performance
– High-single digit increase in oral care; low-single digit increases in medical
solutions, and separation and purification
– Low-single digit decline in health information systems
• Normalization of post-COVID related biopharma demand, and tighter hospital
budgets negatively impacting separation and purification, and health
information systems performance
• Operating margin up 50 bps YoY; up 240 bps sequentially
– YoY increase driven by:
▪ Benefits from productivity actions, restructuring, strong spending
discipline, and price
▪ Partially offset by higher restructuring costs
Organic growth
2.4%
Operating margin
22.2%
Health Care

-- 11 of 22 --

12
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Q3 2023 commentary
• Organic growth performance
– High-single digit declines in home improvement; home health and auto care
– Mid-single digit decline in stationery and office
– Back-to-school season demand trends muted; rising interest rates impacting
housing market and DIY spending
• Operating margin down 70 bps YoY; up 230 bps sequentially
– YoY decline driven by:
▪ Lower sales volume and higher restructuring costs
▪ Headwinds partially offset by benefits from productivity actions,
restructuring, strong spending discipline, and price
Organic growth
-7.2%
Operating margin
20.5%
Consumer

-- 12 of 22 --

2023 Q3 Earnings | October 24, 2023. All rights reserved.
2023 Outlook

-- 13 of 22 --

14
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Implied Q4
• Adjusted sales of $7.6B to $7.7B
– Electronics stabilizing, consumer remains weak, industrial
end-market demand mixed
– Normal seasonal trends (including fewer business days
sequentially due to holidays)
• Adjusted earnings of $2.13 to $2.33 per share, includes:
– Pre-tax restructuring charges of ~$70M to $120M (~$0.10 to
$0.17 per share) vs. ~$10M to $60M prior (driven by Q3
timing impacts)
− Pre-tax restructuring benefits of ~$145M to $195M (~$0.21
to $0.29 per share) vs. ~$185M to $235M prior
Full-year
Adjusted organic sales growth
~-3% vs. lower end of -3% to flat, prior
Includes ~(2) ppt headwind from disposable
respirator decline and 2022 exit of Russia
Increasing adjusted earnings per share
$8.95 to $9.15 vs. $8.60 to $9.10, prior
Pre-tax restructuring charges and benefits
remain unchanged
Raising adjusted free cash flow conversion
100% to 110% vs. 90% to 100%, prior
Raising full-year 2023 EPS and free cash flow guidance

-- 14 of 22 --

2023 Q3 Earnings | October 24, 2023. All rights reserved.
Q&A Mike Roman
Chairman of the Board and
Chief Executive Officer
Monish Patolawala
President and Chief
Financial Officer
Bruce Jermeland
Senior Vice President,
Investor Relations

-- 15 of 22 --

2023 Q3 Earnings | October 24, 2023. All rights reserved.
Appendix

-- 16 of 22 --

17
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Q3 2023 P&L
Note: the term "N/M" used within the appendix references "not meaningful" for certain percent changes.
GAAP ($M)
Q3
2023
Q3
2022 Change
Sales $8,312 $8,619 (3.6)%
Gross profit $3,732 $3,891 (4.1)%
% to sales 44.9% 45.1% (0.2)%
SG&A $5,992 $1,998 N/M
% to sales 72.0% 23.1% 48.9%
R&D & related $430 $461 (6.8)%
% to sales 5.2% 5.4% (0.2)%
Gain on sale of businesses $(36) (2,724) (98.7)%
% to sales (0.4)% (31.6)% 31.2%
Operating income (loss) $(2,654) $4,156 (163.9)%
% to sales (31.9)% 48.2% (80.1)%
Net income (loss) $(2,075) $3,859 (153.8)%
Earnings (loss) per share $(3.74) $6.77 (155.3)%

-- 17 of 22 --

18
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Q3 2023 adjusted sales recap
Americas EMEA APAC Worldwide
Organic growth 0.4% (0.9)% (11.5)% (3.1)%
Acquisitions/divestitures (0.1)% (1.2)% (1.0)% (0.5)%
FX 0.4% 6.5% (2.3)% 0.6%
Total growth 0.7% 4.4% (14.8)% (3.0)%

-- 18 of 22 --

19
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Business segment information
($M) Adjusted net sales* Q3 2023 adjusted sales growth* Adjusted operating income* Adjusted operating margin*
Business Groups
Q3
2023
Q3
2022
Organic
growth FX M&A
Total
sales
change
Q3
2023
Q3
2022 Percent
change
Q3
2023
Q3
2022
Safety & Industrial $2,751 $2,894 (5.8)% 0.9% —% (4.9)% $708 $673 5.4% 25.7% 23.2%
Transportation & Electronics $1,879 $1,889 (1.8)% 0.1% 1.2% (0.5)% $494 $410 20.9% 26.3% 21.7%
Health Care $2,073 $2,076 2.4% 0.8% (3.4)% (0.2)% $460 $450 2.2% 22.2% 21.7%
Consumer $1,315 $1,409 (7.2)% 0.5% —% (6.7)% $269 $299 (10.1)% 20.5% 21.2%
Total Operating Business
Segment $1,931 $1,832
Corporate & Unallocated $2 $1 $(72) $(42)
Total $8,020 $8,269 (3.1)% 0.6% (0.5)% (3.0)% $1,859 $1,790 3.9% 23.2% 21.6%
*"Safety & Industrial", "Transportation & Electronics", "Corporate & Unallocated", "Total Operating Business Segment" and "Total" provided on an adjusted basis while
“Health Care” and “Consumer” are not provided on an adjusted basis

-- 19 of 22 --

20
2023 Q3 Earnings | October 24, 2023. All rights reserved.
Additional GAAP sales detail
($M) GAAP Net Sales
Business Groups Q3 2023 Q3 2022
Abrasives 330 339
Automotive Aftermarket 316 316
Closure and Masking Systems 240 266
Electrical Markets 327 331
Industrial Adhesives and Tapes 544 598
Personal Safety 862 922
Roofing Granules 132 122
Total Safety & Industrial Business Group 2,751 2,894
Advanced Materials 274 297
Automotive and Aerospace 507 437
Commercial Solutions 430 459
Electronics 738 813
Transportation Safety 222 233
Total Transportation & Electronics Business Group 2,171 2,239
($M) GAAP Net Sales
Business Groups Q3 2023 Q3 2022
Food Safety — 63
Health Information Systems 305 312
Medical Solutions 1,179 1,150
Oral Care 331 308
Separation and Purification Sciences 242 235
Other Health Care 16 8
Total Health Care Business Group 2,073 2,076
Construction and Home Improvement Markets 603 656
Home, Health and Auto Care 391 418
Stationery and Office 321 335
Total Consumer Business Group 1,315 1,409
Corporate and Unallocated 2 1
Total 3M 8,312 8,619

-- 20 of 22 --

21
2023 Q3 Earnings | October 24, 2023. All rights reserved.
2023 to 2025 structural reorganization actions*
(($M)
)
Q1 2023
Actual
Q2 2023
Actual
Q3 2023
Actual
Q4 2023
Estimated
FY 2023
Estimated
Total Program
Estimated
Restructuring & related charges $52 $212 $68 $70 to $120 $400 to $450 $700 to $900
Benefits - $89 $166 $145 to $195 $400 to $450 $700 to $900
*Note: These are separate from 3M’s 2023 to 2025 PFAS exit actions.

-- 21 of 22 --



-- 22 of 22 --